Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger
Annals of the Rheumatic Diseases · 2026
DOI: 10.1016/j.ard.2025.08.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Jon Musai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Autoantibodies, Transcription Factors, Mi-2 Nucleosome Remodeling and Deacetylase Complex, Dermatomyositis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Intramural NIH HHS, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
OBJECTIVES: In patients with dermatomyositis with anti-Mi2 autoantibodies, autoantibodies can enter muscle cells, leading to the aberrant expression of genes normally repressed by the Mi2/nucleosome remodelling and deacetylation (NuRD) complex. However, the mechanism by which autoantibodies interfere with Mi2/NuRD function remains unclear. This study aimed to identify additional autoantibodies in anti-Mi2-positive patients and the epitopes recognised by these autoantibodies. METHODS: Phage immunoprecipitation sequencing (PhIP-Seq) was used to screen sera from patients with anti-Mi2 autoantibody-positive myositis. Enzyme-linked immunosorbent assays (ELISAs) and luciferase immunoprecipitation system (LIPS) immunoassays were used to detect autoantibodies in sera from healthy controls, patients with myositis, and those with other autoimmune diseases. RESULTS: PhIP-Seq identified autoantibodies recognising the autoimmune regulator (AIRE) in sera from anti-Mi2 autoantibody-positive patients. Both anti-AIRE and anti-Mi2 autoantibodies predominantly recognised a homologous region containing the plant homeodomain zinc finger type I (PHD1), which is critical for AIRE and Mi2/NuRD function. ELISA and LIPS showed that anti-Mi2 autoantibody-positive patients were positive for anti-AIRE autoantibodies, whereas AIRE reactivity was largely absent in healthy comparators, anti-Mi2 autoantibody-negative myositis, and other autoimmune diseases. Affinity-purified anti-Mi2 autoantibodies recognised both Mi2 and AIRE by ELISA, whereas anti-Mi2-depleted fractions did not recognise either protein. CONCLUSIONS: Autoantibodies targeting Mi2 recognise AIRE at a shared PHD1 epitope - a conserved motif found in numerous transcriptional regulators. These findings support a model in which anti-Mi2 autoantibodies disrupt the Mi2/NuRD complex, and potentially other PHD1-containing proteins, by interfering with chromatin binding, although further studies are needed to directly demonstrate this mechanism in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, Maryland, USA.
- Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, Maryland, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
- Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
Förderung
- NIGMS NIH HHS
- Intramural NIH HHS
- National Institute of Environmental Health Sciences
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Musai, J., Jayaraman, S., Pak, K., Pinal-Fernandez, I., Muñoz-Braceras, S., Casal-Dominguez, M., Cho, E., Fitisemanu, F. M., Burbelo, P. D., Kaplan, M. J., Warner, B. M., Schiffenbauer, A. I., Selva-O'Callaghan, A., Milisenda, J. C., Rider, L. G., Larman, H. B., & Mammen, A. L. (2026). Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.08.023
Vancouver
Musai J, Jayaraman S, Pak K, Pinal-Fernandez I, Muñoz-Braceras S, Casal-Dominguez M, et al. Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2025.08.023
BibTeX
@article{Musai2026,
author = {Musai, Jon and Jayaraman, Sahana and Pak, Katherine and Pinal-Fernandez, Iago and Muñoz-Braceras, Sandra and Casal-Dominguez, Maria and Cho, Eric and Fitisemanu, Fa'alataitaua M and Burbelo, Peter D and Kaplan, Mariana J and Warner, Blake M and Schiffenbauer, Adam I and Selva-O'Callaghan, Albert and Milisenda, José César and Rider, Lisa G and Larman, H Benjamin and Mammen, Andrew L},
title = {Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
doi = {10.1016/j.ard.2025.08.023}
}
EUVIMED